Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for patients with hormone receptor-positive and HER2positive metastatic breast cancer (SYSUCC-002)
Jitteriness, dry mouth, constipation, insomnia, increased heart rate, and higher blood pressure may occur
New results from a randomized clinical trial of semaglutide (brand name Ozempic/ Wegovy) published last week in the New England Journal of Medicine show impressive results for non-alcoholic fatty liver disease as well
Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models
Technical advances have overturned the one cell-one hormone dogma for EECs (44, 45), and thus, L cells co-express GLP-1 with different hormones depending on their location